General Information of Disease (ID: DISR30O9)

Disease Name Charcot-Marie-Tooth disease type 2
Synonyms
autosomal dominant Charcot-Marie-Tooth disease type 2; Charcot-Marie-Tooth type 2; hereditary motor and sensory neuropathy Guadalajara neuronal type; hereditary motor and sensory neuropathy type 2; CMT2; autosomal dominant axonal Charcot-Marie-Tooth disease; hereditary motor and sensory neuropathy Okinawa type
Definition A Charcot-Marie-Tooth disease characterized by abnormalities in the axon of the peripheral nerve cell.
Disease Hierarchy
DIS3BT2L: Charcot marie tooth disease
DISR30O9: Charcot-Marie-Tooth disease type 2
Disease Identifiers
MONDO ID
MONDO_0018993
MESH ID
D002607
UMLS CUI
C0270914
MedGen ID
124378
Orphanet ID
64746
SNOMED CT ID
398187000

Molecular Interaction Atlas (MIA) of This Disease

Molecular Interaction Atlas (MIA)
This Disease Is Related to 9 DTT Molecule(s)
Gene Name DTT ID Evidence Level Mode of Inheritance REF
DNM2 TTVRA5G Strong Genetic Variation [1]
HSPB8 TTY0OJN Strong Genetic Variation [2]
KIF5A TTCJPAH Strong Genetic Variation [3]
RAB7A TTF6WAQ Strong Biomarker [4]
SCN9A TT4G2JS Strong GermlineCausalMutation [5]
TRPV4 TTKP2SU Strong Biomarker [6]
VCP TTHNLSB Strong Genetic Variation [7]
WNK1 TTJ9UMX Strong Genetic Variation [8]
RAB7A TTF6WAQ Definitive Autosomal dominant [9]
------------------------------------------------------------------------------------
⏷ Show the Full List of 9 DTT(s)
This Disease Is Related to 1 DME Molecule(s)
Gene Name DME ID Evidence Level Mode of Inheritance REF
HINT1 DEWJATF Definitive Genetic Variation [10]
------------------------------------------------------------------------------------
This Disease Is Related to 24 DOT Molecule(s)
Gene Name DOT ID Evidence Level Mode of Inheritance REF
BSCL2 OT73V6Y4 Limited Genetic Variation [11]
MFN2 OTPYN8A3 Limited Genetic Variation [12]
SLC25A46 OTFEV9SV Limited Genetic Variation [13]
AARS1 OTW8D813 Strong CausalMutation [14]
AIFM1 OTKPWB7Q Strong Biomarker [4]
DHTKD1 OTDQLSNT Strong Genetic Variation [15]
DNAJB2 OTZHPV5M Strong Genetic Variation [16]
FIG4 OT501PY9 Strong Biomarker [17]
GARS1 OT5B6R9Y Strong Genetic Variation [18]
HOXD10 OT0NOWU2 Strong Biomarker [19]
IGHMBP2 OTAZFPF5 Strong Genetic Variation [20]
KIF1A OT3JVEGV Strong Biomarker [21]
KIF1B OTI1XQTO Strong Biomarker [4]
LRSAM1 OTOKWR6C Strong Biomarker [22]
MAD2L1BP OT2O2IUJ Strong Biomarker [23]
MORC2 OT52A8BJ Strong Biomarker [24]
RETREG1 OTYOSLZX Strong Biomarker [25]
SPTLC1 OTN0Z98K Strong Biomarker [26]
TFG OT2KJENI Strong Genetic Variation [27]
CHCHD10 OTCDHAM6 Definitive Biomarker [28]
GDAP1 OTQE1O25 Definitive Genetic Variation [29]
NEFL OTQESJV4 Definitive Autosomal recessive [9]
NLN OTFRITPU Definitive Genetic Variation [30]
RAB7A OTBSPWMQ Definitive Autosomal dominant [9]
------------------------------------------------------------------------------------
⏷ Show the Full List of 24 DOT(s)

References

1 Magnetic resonance imaging findings of leg musculature in Charcot-Marie-Tooth disease type 2 due to dynamin 2 mutation.J Neurol. 2008 Jul;255(7):986-92. doi: 10.1007/s00415-008-0808-8. Epub 2008 Jun 17.
2 Small heat shock protein B3 (HSPB3) mutation in an axonal Charcot-Marie-Tooth disease family.J Peripher Nerv Syst. 2018 Mar;23(1):60-66. doi: 10.1111/jns.12249. Epub 2018 Feb 6.
3 Hot-spot KIF5A mutations cause familial ALS. Brain. 2018 Mar 1;141(3):688-697. doi: 10.1093/brain/awx370.
4 A novel type of hereditary motor and sensory neuropathy characterized by a mild phenotype.Arch Neurol. 1999 Oct;56(10):1283-8. doi: 10.1001/archneur.56.10.1283.
5 Hereditary sensory and autonomic neuropathy type IID caused by an SCN9A mutation. Neurology. 2013 Apr 30;80(18):1641-9. doi: 10.1212/WNL.0b013e3182904fdd. Epub 2013 Apr 17.
6 Incidence and Clinical Features of TRPV4-Linked Axonal Neuropathies in a USA Cohort of Charcot-Marie-Tooth Disease Type 2.Neuromolecular Med. 2020 Mar;22(1):68-72. doi: 10.1007/s12017-019-08564-4. Epub 2019 Aug 29.
7 Clinical spectrum of valosin containing protein (VCP)-opathy.Muscle Nerve. 2016 Jun;54(1):94-9. doi: 10.1002/mus.24980. Epub 2015 Dec 29.
8 Arthropathy-related pain in a patient with congenital impairment of pain sensation due to hereditary sensory and autonomic neuropathy type II with a rare mutation in the WNK1/HSN2 gene: a case report.BMC Neurol. 2016 Oct 21;16(1):201. doi: 10.1186/s12883-016-0727-8.
9 Technical standards for the interpretation and reporting of constitutional copy-number variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics (ACMG) and the Clinical Genome Resource (ClinGen). Genet Med. 2020 Feb;22(2):245-257. doi: 10.1038/s41436-019-0686-8. Epub 2019 Nov 6.
10 Whole exome sequencing reveals a broader variant spectrum of Charcot-Marie-Tooth disease type 2.Neurogenetics. 2020 Apr;21(2):79-86. doi: 10.1007/s10048-019-00591-4. Epub 2019 Dec 12.
11 Clinical and Molecular Characterization of BSCL2 Mutations in a Taiwanese Cohort with Hereditary Neuropathy.PLoS One. 2016 Jan 27;11(1):e0147677. doi: 10.1371/journal.pone.0147677. eCollection 2016.
12 Enhancing folic acid metabolism suppresses defects associated with loss of Drosophila mitofusin.Cell Death Dis. 2019 Mar 25;10(4):288. doi: 10.1038/s41419-019-1496-2.
13 Reduction of Rpd3 suppresses defects in locomotive ability and neuronal morphology induced by the knockdown of Drosophila SLC25A46 via an epigenetic pathway.Exp Cell Res. 2019 Dec 15;385(2):111673. doi: 10.1016/j.yexcr.2019.111673. Epub 2019 Oct 12.
14 Hypermorphic and hypomorphic AARS alleles in patients with CMT2N expand clinical and molecular heterogeneities.Hum Mol Genet. 2018 Dec 1;27(23):4036-4050. doi: 10.1093/hmg/ddy290.
15 A nonsense mutation in DHTKD1 causes Charcot-Marie-Tooth disease type 2 in a large Chinese pedigree. Am J Hum Genet. 2012 Dec 7;91(6):1088-94. doi: 10.1016/j.ajhg.2012.09.018. Epub 2012 Nov 8.
16 HSJ1-related hereditary neuropathies: novel mutations and extended clinical spectrum. Neurology. 2014 Nov 4;83(19):1726-32. doi: 10.1212/WNL.0000000000000966. Epub 2014 Oct 1.
17 Mutation of FIG4 causes neurodegeneration in the pale tremor mouse and patients with CMT4J. Nature. 2007 Jul 5;448(7149):68-72. doi: 10.1038/nature05876. Epub 2007 Jun 17.
18 Dimerization is required for GARS-mediated neurotoxicity in dominant CMT disease.Hum Mol Genet. 2016 Apr 15;25(8):1528-42. doi: 10.1093/hmg/ddw031. Epub 2016 Feb 7.
19 A HOX gene mutation in a family with isolated congenital vertical talus and Charcot-Marie-Tooth disease. Am J Hum Genet. 2004 Jul;75(1):92-6. doi: 10.1086/422015. Epub 2004 May 14.
20 IGHMBP2-related clinical and genetic features in a cohort of Chinese Charcot-Marie-Tooth disease type 2 patients.Neuromuscul Disord. 2017 Feb;27(2):193-199. doi: 10.1016/j.nmd.2016.11.008. Epub 2016 Nov 18.
21 De novo mutations in the motor domain of KIF1A cause cognitive impairment, spastic paraparesis, axonal neuropathy, and cerebellar atrophy. Hum Mutat. 2015 Jan;36(1):69-78. doi: 10.1002/humu.22709. Epub 2014 Nov 27.
22 Mutation in the gene encoding ubiquitin ligase LRSAM1 in patients with Charcot-Marie-Tooth disease. PLoS Genet. 2010 Aug 26;6(8):e1001081. doi: 10.1371/journal.pgen.1001081.
23 Charcot-Marie-Tooth disease type 2 associated with mutation of the myelin protein zero gene.Neurology. 1998 May;50(5):1397-401. doi: 10.1212/wnl.50.5.1397.
24 Hyperactivation of HUSH complex function by Charcot-Marie-Tooth disease mutation in MORC2.Nat Genet. 2017 Jul;49(7):1035-1044. doi: 10.1038/ng.3878. Epub 2017 Jun 5.
25 Mutations in FAM134B, encoding a newly identified Golgi protein, cause severe sensory and autonomic neuropathy. Nat Genet. 2009 Nov;41(11):1179-81. doi: 10.1038/ng.464. Epub 2009 Oct 18.
26 Hereditary sensory neuropathy type 1 is caused by the accumulation of two neurotoxic sphingolipids.J Biol Chem. 2010 Apr 9;285(15):11178-87. doi: 10.1074/jbc.M109.092973. Epub 2010 Jan 22.
27 A novel TFG mutation causes Charcot-Marie-Tooth disease type 2 and impairs TFG function. Neurology. 2014 Sep 2;83(10):903-12. doi: 10.1212/WNL.0000000000000758. Epub 2014 Aug 6.
28 CHCHD10 mutations promote loss of mitochondrial cristae junctions with impaired mitochondrial genome maintenance and inhibition of apoptosis.EMBO Mol Med. 2016 Jan 1;8(1):58-72. doi: 10.15252/emmm.201505496.
29 A novel autosomal dominant GDAP1 mutation in an Italian CMT2 family.J Peripher Nerv Syst. 2012 Sep;17(3):351-5. doi: 10.1111/j.1529-8027.2012.00414.x.
30 Evaluation of Respiratory Muscle Strength and Pulmonary Function in Patients with Charcot-Marie-Tooth Disease Type 2.Eur Neurol. 2015;74(5-6):310-4. doi: 10.1159/000442282. Epub 2015 Dec 17.